Marc C. Deller

Dr. Marc Deller is Co-Founder and Chief Scientific Officer (CSO) of Elora Therapeutics. He is a globally recognized leader in Structure-Based Drug Design (SBDD) and drug discovery, with over 20 years of experience across academia, biotech, and pharma. He is known for pioneering innovations in protein science, X-ray crystallography, Cryo-Electron Microscopy (Cryo-EM), and AI-driven SBDD.

Dr. Deller has held senior scientific roles at Incyte Pharmaceuticals, Stanford University, Scripps Research Institute, and Pfizer. There, he established and led automated structural biology platforms, managed multi-million-dollar research budgets, and mentored cross-functional teams in high-impact therapeutic programs involving cytokine-based receptor tyrosine kinase, cell surface receptors, antibodies, and small-molecule therapeutics.

His work has contributed to more than 6 oncology, virology, and immunology programs reaching FDA IND filings, and he has published over 60 manuscripts and 3 patents in the field of protein science and SBDD.

Marc completed his post-doctoral research at Yale University and received his PhD in Structural Biology from University of Oxford. He earned his bachelor’s degree in Biochemistry and Molecular Biology from University of Leeds.

October 2025